Sarcomatous hepatocellular carcinoma: A special reference to ordinary hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 4, 2003, Pages 415-423

  Nishi, Hidehiro ^a   Taguchi, Ken Ichi ^a   Asayama, Yoshiki ^a   Aishima, Shin Ichi ^a   Sugimachi, Keishi ^a   Nawata, Hajime ^a   Tsuneyoshi, Masazumi ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Beta catenin; E cadherin; Hepatocellular carcinoma; Mib1 (Ki67); Sarcomatous

Indexed keywords

UVOMORULIN;

ARTICLE; CANCER GRADING; CANCER GROWTH; CELL ADHESION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER SARCOMA; MORPHOLOGY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0038218491     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.02888.x     Document Type: Article

References (29)

1. Jaffe RH. Sarcoma and carcinoma of liver following cirrhosis. Arch. Intern. Med. 1924; 33: 330-42.
2. Edmondoson HA, Steiner PE. Primary carcinoma of the liver. A study of 100 cases among 48900 necropsies. Cancer 1954; 7: 462-503.
3. Chang WL, Agha FP, Morgan WS. Primary sarcoma of the liver in the adult. Cancer 1983; 51: 1510-17.
4. Kuwano H, Sonoda T, Hashimoto H, Enjoji M. Hepatocellular carcinoma with osteoclast-like giant cells. Cancer 1984; 54: 837-42.
5. Shibasaki K, Kojima N, Fujita K et al. Long-term survival in cases of hepatocellular carcinoma and clinicopathological study: Three cases of protracted clinical course. Acta Hepatol. Jpn 1975; 16: 431-40 (in Japanese).
6. Isomura T, Arakawa M, Wada T, Shimokawa Y. Hepatocellular carcinoma with sarcoma-like transformation: a case report. Acta Hepatol. Jpn 1979; 20: 70-5 (in Japanese).
7. Shin P, Ohmi S, Sakurai K, Kaku K, Takahashi M. Hepatic carcinoma combined with hepatic sarcoma. Acta Pathol. Jpn 1981; 31: 815-24.
8. Nagamine Y, Sasaki K, Kaku K, Takahashi M. Hepatic sarcoma associated with hepatoma. Acta Pathol. Jpn 1978; 28: 645-51.
9. Tsujimoto M, Aozaka K, Nakajima Y, Kariya M. Hepatocellular carcinoma with sarcomatous proliferation showing an unusual and widespread metastasis. Acta Pathol. Jpn 1984; 34: 839-45.
10. Carig JR, Peters RL, Edmondson HA. Tumors of the liver and intrahepatic bile ducts. Atlas of tumor pathology, Fascicle 26, Series, 2. Washington DC: Armed Forces Institute of Pathology, 1989; 179-80.
11. Ishak KG, Anthony PP, Sobin LH. Histological Typing of Tumors of the Liver, 2nd edn. Geneva: World Health Organization, 1994.
12. Kojiro M, Sugihara S, Kakizoe S, Nakashima O, Kiyomatsu K. Hepatocellular carcinoma with sarcomatous change; a special reference to the relationship with anticancer therapy. Cancer Chemother. Pharmacol. 1989; 23: 4-8.
13. Maeda T, Adachi E, Kajiyama K, Takenaka K, Sugimachi K, Tsuneyoshi M. Spindle cell hepatocellular carcinoma: A clinicopathologic and immunohistochemical analysis of 15 cases. Cancer 1996; 77: 51-7.
14. Takeichi M. The cadherins: Cell-cell adhesion molecules controlling animal morphogenesis. Development 1988; 102: 639-55.
15. Shinoyama Y, Hirohashi S, Hirano S et al. Cadherin cell-adhesion molecules in human epithelial tissue and carcinomas. Cancer Res. 1989; 49: 2128-33.
16. Oyama T, Kanai Y, Ochiai A et al. A truncated β-catenin disrupts the interaction between E-cadherin and α-catenin: A case of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res. 1994; 54: 6282-7.
17. Gumbiner BM. Signal transduction by β-catenin. Curr. Opin. Cell Biol. 1995; 7: 634-40.
18. Ihara A, Koizumi H, Hashizume R, Uchikochi T. Expression of epithelial cadherin and α- and β-catenins in nontumoral livers and hepatocellular carcinomas. Hepatology 1996; 23: 1441-7.
19. Huang G, Lee H, Chen C, Sheu J, Chiou L, Chen D. Correlation of E-cadherin expression and recurrence of hepatocellular carcinoma. Hepatogastroenterology 1999; 46: 1923-7.
20. Shimoyama Y, Hirohashi S. Cadherin intercellular adhesion molecule in hepatocellular carcinoma: Loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett. 1991; 57: 131-5.
21. Kozyraki R, Scoazec JY, Flejou JF et al. Expression of cadherin and α-catenin in primary epithelial tumor of liver. Gastroenterology 1996; 110: 1137-49.
22. Rosai J. Gastrointestinal tract. In: Stamathis G, ed. Ackerman's Surgical Pathology, Vol. 1. St Louis: Mosby, 1989; 487-522
23. Barth AL, Nathke IS, Nelson WJ. Cadherins, catenins, and APC protein: Interplay between cytoskeletal complexes and signaling pathway. Curr. Opin. Cell Biol. 1997; 9: 683-90.
24. Behrens J, von Kries JP, Kuhl M et al. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 1996; 382: 638-42.
25. Kondo Y, Kanai Y, Sakamoto M et al. Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma. Jap J. Cancer Res. 1999; 90: 1301-9.
26. Nhieu JTV, Renard CA, Wei Y, Cherqui D, Zafrani ES, Buendia MA. Nuclear accumulation of mutated β-catenin in hepatocellular carcinoma is associated with increased cell proliferation. Am. J. Pathol. 1999; 155: 703-10.
27. Huang H, Fujii H, Sankila A et al. β-Catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am. J. Pathol. 1999; 155: 1795-801.
28. Kakizoe S, Kojiro M, Nakashima T. Hepatocellular carcinoma with sarcomatous change: Clinicopathologic and immunohistochemical studies of 14 autopsy cases. Cancer 1987; 59: 310-16.
29. Genda T, Sakamoto M, Ichida T, Asakura H, Hirohashi S. Loss of cell-cell cantact is indicated by integrin-motile and highly-metastatic hepatocellular carcinoma cells. Lab. Invest. 2000; 80: 387-94.